ABMD has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
ABMD has been removed from your Stock Email Alerts list.
GuruFocus Financial Strength Rank measures how strong a companys financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| vs
industry |
vs
history |
||
|---|---|---|---|
| Cash to Debt | No Debt |
ABMD's Cash to Debt is ranked higher than
65% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 3750.67 vs. ABMD: No Debt ) |
ABMD'
s 10-Year Cash to Debt Range
Min: 382.22 Max: No Debt Current: No Debt |
| Interest Coverage | No Debt |
ABMD's Interest Coverage is ranked higher than
68% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 420.30 vs. ABMD: No Debt ) |
ABMD'
s 10-Year Interest Coverage Range
Min: No Debt Max: No Debt Current: No Debt |
| F-Score: 5 |
|
| Z-Score: 16 |
|
| M-Score: -2.63 |
|
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank
| vs
industry |
vs
history |
||
|---|---|---|---|
| Operating margin (%) | 10.10 |
ABMD's Operating margin (%) is ranked higher than
78% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 5.80 vs. ABMD: 10.10 ) |
ABMD'
s 10-Year Operating margin (%) Range
Min: -91.7 Max: 10.1 Current: 10.1 |
| Net-margin (%) | 9.1 |
ABMD's Net-margin (%) is ranked higher than
85% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 3.25 vs. ABMD: 9.1 ) |
ABMD'
s 10-Year Net-margin (%) Range
Min: -80.7 Max: 9.1 Current: 9.1 |
| Revenue Growth (%) | 11.4 |
ABMD's Revenue Growth (%) is ranked higher than
93% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 2.40 vs. ABMD: 11.4 ) |
ABMD'
s 10-Year Revenue Growth (%) Range
Min: -3.5 Max: 11.4 Current: 11.4 |
| Paul Tudor Jones 23,600 sh (+116.51%) RS Investment Management 887,980 sh (+72.02%) Jim Simons 243,023 sh (+30.43%) | PRIMECAP Management 5,006,690 sh (-0.17%) Pioneer Investments 373,372 sh (-23.32%) |
| Steven Cohen 18,060 sh (New) Pioneer Investments 497,960 sh (+33.37%) Paul Tudor Jones 31,100 sh (+31.78%) | PRIMECAP Management 5,006,690 sh (unchged) | Jim Simons 221,223 sh (-8.97%) RS Investment Management 491,180 sh (-44.69%) |
| Paul Tudor Jones 39,100 sh (+25.72%) Pioneer Investments 563,603 sh (+13.18%) Jim Simons 234,323 sh (+5.92%) PRIMECAP Management 5,297,690 sh (+5.81%) | RS Investment Management Sold Out Steven Cohen 1,000 sh (-94.46%) |
| Steven Cohen 18,973 sh (+1797.3%) PRIMECAP Management 5,751,990 sh (+8.58%) | Jim Simons Sold Out Paul Tudor Jones Sold Out Pioneer Investments 437,683 sh (-22.34%) |
| Guru | Date | Trades | Impact to Portfolio | Price Range * (?) | Current Price | Change from Average | Current Shares | |
|---|---|---|---|---|---|---|---|---|
| PRIMECAP Management | 2011-06-30 | Add 28.42% | 0.02% | $14.65 - $18.94 | $ 23.33 | 39% | 3772973 | |
| PRIMECAP Management | 2010-06-30 | Add 20.11% | 0.01% | $8.61 - $10.15 | $ 23.33 | 145% | 2551673 |
More recent guru trades are included for Premium Members only!!
| vs
industry |
vs
history |
||
|---|---|---|---|
| P/E(ttm) | 63.00 |
ABMD's P/E(ttm) is ranked higher than
57% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 24.10 vs. ABMD: 63.00 ) |
ABMD'
s 10-Year P/E(ttm) Range
Min: 36.46 Max: 946.92 Current: 63 |
| P/S | 6.00 |
ABMD's P/S is ranked lower than
78% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 1.70 vs. ABMD: 6.00 ) |
ABMD'
s 10-Year P/S Range
Min: 2.16 Max: 27.02 Current: 6 |
| PFCF | 56.80 |
ABMD's PFCF is ranked lower than
53% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 18.60 vs. ABMD: 56.80 ) |
ABMD'
s 10-Year PFCF Range
Min: 23.56 Max: 2462 Current: 56.8 |
| EV-to-EBIT | 47.6 |
ABMD's EV-to-EBIT is ranked lower than
53% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 16.25 vs. ABMD: 47.6 ) |
ABMD'
s 10-Year EV-to-EBIT Range
Min: 27 Max: 694.7 Current: 47.6 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Price/Median PS Value | 0.9 |
ABMD's Price/Median PS Value is ranked higher than
72% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 0.80 vs. ABMD: 0.9 ) |
ABMD'
s 10-Year Price/Median PS Value Range
Min: 0.4 Max: 2 Current: 0.9 |
| Earnings Yield (Greenblatt) | 2.10 |
ABMD's Earnings Yield (Greenblatt) is ranked higher than
65% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 5.95 vs. ABMD: 2.10 ) |
ABMD'
s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1 Max: 3.7 Current: 2.1 |
| Forward Rate of Return (Yacktman) | -0.99 |
ABMD's Forward Rate of Return (Yacktman) is ranked higher than
88% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 3.03 vs. ABMD: -0.99 ) |
ABMD'
s 10-Year Forward Rate of Return (Yacktman) Range
Min: -3.4 Max: -1.2 Current: -0.99 |
| Industry: | Medical Devices | |
|---|---|---|
| Compare: | MDT, SYK, SMA, ZMH, STJ | |
| Traded in other countries: | AIO.Germany |